Search results
Results From The WOW.Com Content Network
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter . [ 4 ]
The Health Valley covers the Western Switzerland region, where the life sciences sector extends from Geneva to Bern, including the seven cantons of Bern, Fribourg, Geneva, Jura, Neuchâtel, Valais and Vaud. This cluster presents a critical mass of 1,000 companies, research centers and innovation support structures, representing today more than ...
70% of the investments in life sciences in Europe are made in the United Kingdom, Germany, Ireland, the Netherlands, France, and Switzerland. [4] [5] In addition to pharmaceutical companies (65 companies), Switzerland is home to many companies in the fields of biotechnology (338 companies) or medical devices and technology (341 companies).
On Wednesday, during its annual investor conference, Edwards Lifesciences Corporation (NYSE:EW) detailed its strategy for sustained long-term growth and innovations in structural heart therapies.
(Reuters) -Edwards Lifesciences on Monday said it has agreed to sell its critical care products unit to Becton Dickinson in an all-cash deal valued at $4.2 billion to sharpen focus on its heart ...
Edwards, Kentucky, in Logan County (see April 2, 2006 tornado outbreak) Edwards Dam, a former dam on the Kennebec River in Maine; Edwards, Michigan; Edwards, Mississippi; Edwards, Missouri; Edwards (town), New York; Edwards (village), New York; Edwards, Wisconsin; Edwards Air Force Base, in California; Edwards Plateau region of Texas Edwards ...
Genentech's corporate headquarters are in South San Francisco, California), with additional manufacturing facilities in Vacaville, California; Oceanside, California; and Hillsboro In March 2024, it was announced the Swiss pharmaceutical company, Lonza had acquired the Vacaville site from parent-company, Roche for $1.2 billion.
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, [2] and Morges, Switzerland. [3] The company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991 [4] and Incyte Genomics, Inc. of Delaware. [5]